EUVIMEDEUVIMED entdecken
Crossref

A magnetic-guided nano-antibacterial platform for alternating magnetic field controlled vancomycin release in staphylococcus aureus biofilm eradication

Zhi Huang, Yuankai Li, Wang Yin, Randy Bachelard Nziengui Raby, Haifeng Liang iD, Bo Yu

Drug Delivery and Translational Research · 2025

DOI: 10.1007/s13346-024-01667-x ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Delivery and Translational Research, 2025. Verfasst von Zhi Huang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biomedical Engineering, School of Basic Medical Sciences, Central South University, Changsha, 410083, China. Hauptthemen laut MEDLINE: Vancomycin, Biofilms, Anti-Bacterial Agents, Staphylococcus aureus. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province, Science and Technology Development Plan Project of Chenzhou.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bacterial resilience within biofilms, rendering them up to 1000 times more resistant to antibiotic drugs, poses a formidable challenge. This study introduces a targeted biofilm eradication strategy, termed "target-penetration-killing-eradication", implemented through magnetic micro-robotic technology. Specifically, we present the development of a magnetic-guided nano-antibacterial platform designed for alternating magnetic field (AMF) controlled vancomycin release in the eradication of Staphylococcus aureus biofilms. To address the issue of premature vancomycin release in physiological conditions, we employed a temperature-sensitive linking agent, 4,4'-azobis(4-cyano valeric acid), facilitating the conjugation of vancomycin onto Fe3O4/CS nanocomposites, resulting in the novel construct Fe3O4@CS-ACVA-VH. The release mechanism adheres to first-order kinetics and Fickian diffusion, with each 10-min AMF treatment releasing approximately 8.4 ± 1.1% of vancomycin. The potency of vancomycin in the release solution was similar to that of the original drug (MIC: 7.4 ± 3.5 vs. 5.6 μg/mL). Fe3O4@CS-ACVA-VH exhibited sustained antibacterial efficacy, inhibiting bacterial growth for four consecutive days and preventing the formation of bacterial biofilms on its surface. Contact-inhibition bacterial activity of Fe3O4@CS-ACVA-VH against S. aureus was 0.046875 mg/mL. Conceptually validating our approach, we emphasize Fe3O4@CS-ACVA-VH's exceptional ability to penetrate S. aureus biofilms under static magnetic field attraction. Furthermore, the nano-platform offers the unique advantage of on-demand vancomycin release through alternating magnetic field stimulation, effectively clearing a larger biofilm area. This multifunctional nano-platform demonstrates magnetic-guided biofilm penetration followed by controlled vancomycin release, presenting a promising strategy for enhanced biofilm eradication.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VancomycinBiofilmsAnti-Bacterial AgentsStaphylococcus aureusMagnetic FieldsDrug LiberationDelayed-Action PreparationsMicrobial Sensitivity TestsNanocomposites

Stichwörter der Autor:innen

Alternating Magnetic FieldBiofilmsControlled releaseFe3O4

Substanzen

VancomycinAnti-Bacterial AgentsDelayed-Action Preparations

Autor:innen und Institutionen

  • Institute of Biomedical Engineering, School of Basic Medical Sciences, Central South University, Changsha, 410083, China.
  • Orthopedic and Traumatology Department, Zhujiang Hospital, Southern Medical University, Guangzhou, 510282, China. lianghaifong@qq.com.
  • Department of Orthopedics, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, 510150, China. lianghaifong@qq.com.
  • Orthopedic and Traumatology Department, Zhujiang Hospital, Southern Medical University, Guangzhou, 510282, China. gzyubo@163.com.

ORCID-Profile: Haifeng Liang

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Guangdong Province
  • Science and Technology Development Plan Project of Chenzhou

Zitieren

APA

Huang, Z., Li, Y., Yin, W., Raby, R. B. N., Liang, H., & Yu, B. (2025). A magnetic-guided nano-antibacterial platform for alternating magnetic field controlled vancomycin release in staphylococcus aureus biofilm eradication. Drug Delivery and Translational Research. https://doi.org/10.1007/s13346-024-01667-x

Vancouver

Huang Z, Li Y, Yin W, Raby RBN, Liang H, Yu B. A magnetic-guided nano-antibacterial platform for alternating magnetic field controlled vancomycin release in staphylococcus aureus biofilm eradication. Drug Delivery and Translational Research. 2025. doi:10.1007/s13346-024-01667-x

BibTeX
@article{Huang2025,
  author = {Huang, Zhi and Li, Yuankai and Yin, Wang and Raby, Randy Bachelard Nziengui and Liang, Haifeng and Yu, Bo},
  title = {A magnetic-guided nano-antibacterial platform for alternating magnetic field controlled vancomycin release in staphylococcus aureus biofilm eradication},
  journal = {Drug Delivery and Translational Research},
  year = {2025},
  doi = {10.1007/s13346-024-01667-x}
}
Kostenlos starten →